{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:29:17Z","timestamp":1791811757435,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-112-6"],"award-info":[{"award-number":["CI-112-6"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-110-2320-B-010-008-MY2"],"award-info":[{"award-number":["MOST-110-2320-B-010-008-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-111-2314-B-A49-036-MY3"],"award-info":[{"award-number":["MOST-111-2314-B-A49-036-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bbrc.2024.149489","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T04:08:52Z","timestamp":1704946132000},"page":"149489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["ALDOA coordinates PDE3A through the \u03b2-catenin\/ID3 axis to stimulate cancer metastasis and M2 polarization in lung cancer with EGFR mutations"],"prefix":"10.1016","volume":"696","author":[{"given":"Chia-Ying","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-His","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-4937","authenticated-orcid":false,"given":"Chi-Ying F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-9935","authenticated-orcid":false,"given":"Yu-Chan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.149489_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10204675","article-title":"Survival and treatment of lung cancer in Taiwan between 2010 and 2016","volume":"10","author":"Chang","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2024.149489_bib2","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.21037\/tlcr-22-235","article-title":"Multiple mutations in the EGFR gene in lung cancer: a systematic review","volume":"11","author":"Casta\u00f1eda-Gonz\u00e1lez","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib3","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.21037\/tcr.2018.10.06","article-title":"EGFR first- and second-generation TKIs-there is still place for them in EGFR-mutant NSCLC patients","volume":"8","author":"Karachaliou","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-023-01082-8","article-title":"Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2024.149489_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010146","article-title":"First- and second-generation EGFR-TKIs are all replaced to osimertinib in chemo-Naive EGFR mutation-positive non-small cell lung cancer?","volume":"20","author":"Takeda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.149489_bib6","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrc.2024.149489_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.20892\/j.issn.2095-3941.2022.0540","article-title":"Targeting the EGF receptor family in non-small cell lung cancer-increased complexity and future perspectives","volume":"19","author":"Boch","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbrc.2024.149489_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.acr.2018.02.003","article-title":"Acquired resistance to drugs targeting tyrosine kinases","volume":"138","author":"Rosenzweig","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.tem.2018.05.003","article-title":"Roles of aldolase family genes in human cancers and diseases","volume":"29","author":"Chang","year":"2018","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2024.149489_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cmet.2018.04.003","article-title":"Aldolase B-mediated fructose metabolism drives metabolic reprogramming of colon cancer liver metastasis","volume":"27","author":"Bu","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2024.149489_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091238","article-title":"Enrichment of aldolase C correlates with low non-mutated IDH1 expression and predicts a favorable prognosis in glioblastomas","volume":"11","author":"Chang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2024.149489_bib12","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.18632\/aging.204010","article-title":"The role of fructose 1,6-bisphosphate-mediated glycolysis\/gluconeogenesis genes in cancer prognosis","volume":"14","author":"Li","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.bbrc.2024.149489_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2017.06.001","article-title":"Feedback regulation of ALDOA activates the HIF-1\u03b1\/MMP9 axis to promote lung cancer progression","volume":"403","author":"Chang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2024.149489_bib14","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-18-4080","article-title":"Therapeutic targeting of aldolase A interactions inhibits lung cancer metastasis and prolongs survival","volume":"79","author":"Chang","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41419-020-2387-2","article-title":"Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct 4\/DUSP4\/TRAF4 axis and the acquisition of lung cancer stemness","volume":"11","author":"Chang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2024.149489_bib16","article-title":"Aldolase A and phospholipase D1 synergistically resist alkylating agents and radiation in lung cancer","volume":"11","author":"Chang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2024.149489_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0031-1301327","article-title":"Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshop","volume":"44","author":"Stratakis","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/157015911798376271","article-title":"cGMP signaling, phosphodiesterases and major depressive disorder","volume":"9","author":"Reierson","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrc.2024.149489_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1057083","article-title":"Recent developments of phosphodiesterase inhibitors: clinical trials, emerging indications and novel molecules","volume":"13","author":"Bondarev","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.149489_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040696","article-title":"Phosphodiesterase inhibitors as a therapeutic approach to neuroprotection and repair","volume":"18","author":"Knott","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.149489_bib21","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.201300188","article-title":"Second act: drug repurposing gets a boost as academic researchers join the search for novel uses of existing drugs","volume":"110","author":"Nair","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.149489_bib22","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/gb-2006-7-7-r61","article-title":"A method for high-throughput gene expression signature analysis","volume":"7","author":"Peck","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbrc.2024.149489_bib23","doi-asserted-by":"crossref","first-page":"113444","DOI":"10.18632\/oncotarget.23049","article-title":"Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients","volume":"8","author":"Yeh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2024.149489_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3164\/jcbn.22-47","article-title":"ETV1 inhibition depressed M2 polarization of tumor-associated macrophage and cell process in gastrointestinal stromal tumor via down-regulating PDE3A","volume":"72","author":"Guo","year":"2023","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.bbrc.2024.149489_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2018.00480","article-title":"CD5L promotes M2 macrophage polarization through autophagy-mediated upregulation of ID3","volume":"9","author":"Sanjurjo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2024.149489_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ijc.32097","article-title":"Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: a meta-analysis","volume":"145","author":"Yi","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2024.149489_bib27","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1158\/1078-0432.CCR-08-1455","article-title":"Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib","volume":"14","author":"Costa","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib28","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1177\/1078155220931926","article-title":"Afatinib for the treatment of EGFR mutation-positive NSCLC: a review of clinical findings","volume":"26","author":"Harvey","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.bbrc.2024.149489_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3892\/ol.2022.13528","article-title":"Drug resistance mechanisms and progress in the treatment of EGFR-mutated lung adenocarcinoma","volume":"24","author":"Sun","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2024.149489_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207462","article-title":"Therapeutic implications for PDE2 and cGMP\/cAMP mediated crosstalk in cardiovascular diseases","volume":"21","author":"Sadek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.149489_bib32","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral Dis."},{"key":"10.1016\/j.bbrc.2024.149489_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/704872","article-title":"A meta-analysis of osteosarcoma outcomes in the modern medical era","volume":"2012","author":"Allison","year":"2012","journal-title":"Sarcoma"},{"key":"10.1016\/j.bbrc.2024.149489_bib34","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.suronc.2010.08.004","article-title":"Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma","volume":"20","author":"Korpi","year":"2011","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.bbrc.2024.149489_bib35","first-page":"1680","article-title":"Snail interacts with Id2 in the regulation of TNF-alpha-induced cancer cell invasion and migration in OSCC","volume":"5","author":"Zhou","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbrc.2024.149489_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<471::AID-MPO2>3.0.CO;2-M","article-title":"Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma","volume":"31","author":"Himelstein","year":"1998","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.bbrc.2024.149489_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.onc.1208188","article-title":"Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1","volume":"24","author":"Swarbrick","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2024.149489_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.149489_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1349-7006.2005.00113.x","article-title":"Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer","volume":"96","author":"Tsuchiya","year":"2005","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2024.149489_bib40","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1074\/jbc.274.10.6035","article-title":"Interaction of the small G protein RhoA with the C terminus of human phospholipase D1","volume":"274","author":"Yamazaki","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.149489_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2010.01.031","article-title":"Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells","volume":"294","author":"Kang","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2024.149489_bib42","article-title":"Phosphodiesterase 3\/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.149489_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrc3638","article-title":"The ID proteins: master regulators of cancer stem cells and tumour aggressiveness","volume":"14","author":"Lasorella","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2024.149489_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1535-6108(03)00141-7","article-title":"Id proteins in cell growth and tumorigenesis","volume":"3","author":"Sikder","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2024.149489_bib45","article-title":"BMP4 signaling is able to induce an epithelial-mesenchymal transition-like phenotype in Barrett's esophagus and esophageal adenocarcinoma through induction of SNAIL2","volume":"11","author":"Kestens","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.149489_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-5876-11-13","article-title":"Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy","volume":"11","author":"Casta\u00f1on","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2024.149489_bib47","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/cgt.2015.38","article-title":"Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity","volume":"22","author":"Chen","year":"2015","journal-title":"Cancer Gene Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2400024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2400024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:51:43Z","timestamp":1762095103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2400024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":47,"alternative-id":["S0006291X2400024X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149489","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALDOA coordinates PDE3A through the \u03b2-catenin\/ID3 axis to stimulate cancer metastasis and M2 polarization in lung cancer with EGFR mutations","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"149489"}}